Current medical design, manufacture news

Nederman acquires RoboVent

The environmental technology company Nederman has acquired industrial air filtration company RoboVent, strengthening its North American position within the U.S. weld fume extraction segment.

Combining RoboVent’s strengths – sales, equipment range, and turnkey capabilities – with Nederman’s global footprint, complementary products, solutions, and digital technology will further enhance ability to deliver clean air solutions within served industrial segments. RoboVent is headquartered in Sterling Heights, Michigan, with more than 100 employees throughout the U.S., Canada, and Mexico and will become part of Nederman´s Extraction & Filtration Technology Division.

Data Inventions, Lojic acquired by ECI Software Solutions

ECI Software Solutions has acquired Data Inventions Inc. and Lojic LLC.

Data Inventions is the maker of a data connectivity and manufacturing intelligence platform called Alora. Lojic is the maker of a customizable visualization and data analytic solution helping manufacturers create and display actionable, real-time insights.

Alora and Lojic connect and analyze data from ERP business systems and shop floor data sources, visualizing production performance in real-time. Alora integrates out-of-the-box with ECI’s JobBOSS, JobBOSS2, M1, and Macola ERP systems, while Lojic integrates with ECI’s JobBOSS. ECI customers can take full advantage of the Alora and Lojic benefits with lightweight implementation, training, and support to guide their teams to success.

Jordi Labs acquired by RQM+

RQM+, has acquired Jordi Labs, expanding its comprehensive regulatory, quality, clinical, and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

“As the only medtech service provider rooted in almost 40 years of regulatory strategy, RQM+ is proud to now offer proprietary testing services for extractables and leachables, which gives our customers the fastest path to regulatory approvals,” says CEO Margaret Keegan.